Segal Paul 4
4 · Alphatec Holdings, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
L-5 Healthcare Partners, LLC
10% OwnerOther
Transactions
- Tax Payment
Common Stock
2023-02-17$14.60/sh−562,327$8,209,974→ 12,781,538 total - Exercise/Conversion
Common Stock
2023-02-17$3.50/sh+2,346,032$8,211,112→ 13,343,865 total - Exercise of In-Money
Warrants to Purchase Common Stock
2023-02-17−2,346,032→ 0 totalExercise: $3.50From: 2018-05-17Exp: 2023-05-17→ Common Stock (2,346,032 underlying)
Footnotes (4)
- [F1]Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.
- [F2]Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.
- [F3]Represents a "cashless exercise" of outstanding warrants. The reporting person received 1,783,705 shares of Common Stock on cashless exercise of warrants to purchase 2,346,032 shares of Common Stock. The Company withheld 562,327 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on February 16, 2023 of approximately $14.60, pursuant to the terms of the warrant.
- [F4]Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.